MannKind Corp Shares Tumble 48% After Sanofi Pulls Out Of Collaboration

Today shares of MannKind Corporation (MNKD) tumbled 48% after it had announced that it had terminated a collaboration agreement with Sanofi Aventis for diabetes drug Afrezza.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.